S1700 SGLT-2 Inhibitors: A Therapeutic Avenue for Non-Alcoholic Fatty Liver Disease, Demonstrating Improvements in Imaging Biomarkers and Histological Features, Including Reduced Hepatic Fibrosis, and Ballooning
American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S1237-S1238
10.14309/01.ajg.0001036168.91510.a6